Recent studies have revealed a correlation between drugs such as Ozempic and similar GLP-1 medications like Wegovy and Mounjaro. dpa/picture alliance via Getty Images “I was devastated,” he said.

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on ...

Novo Nordisk stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Getty Images The new sites will be announced later ... at $906.70 a share. The company stock has soared more than 16% since Jan. 1. While many pharmaceuticals are produced domestically, a ...

Kourtney Kardashian's ex, Scott Disick, admitted to using Mounjaro on a recent episode of The Kardashians which hit our ...

The latest weight-loss drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have list ... company that's worth nearly $830 billion. The stock has risen 17% in the past year, and more than ...

Eli Lilly is a stock that’s been on a tear over the past year, with its incredible upside performance tied to its GLP-1 drug Mounjaro. Let’s dive into what analysts believe could be in store ...

Alcohol doesn’t directly affect how Mounjaro works. But drinking alcohol during treatment with Mounjaro can worsen some of Mounjaro’s side effects. And it can make it difficult for Mounjaro to ...

What's a monster stock? In my book, it's a company that's built a long track record of earnings growth thanks to a solid ...

Amgen released financial results for the 4th quarter of 2024. Check out why I continue to cover AMGN stock with a 'Buy' rating.